Theriva Biologics
(NYSEMKT) TOVX
Theriva Biologics Financials at a Glance
Market Cap
$17.49M
Revenue (TTM)
$0.00
Net Income (TTM)
$25.25M
EPS (TTM)
$-4.04
P/E Ratio
-0.09
Dividend
$0.00
Beta (Volatility)
0.90 (Low)
Dividend
$0.00
Beta (Volatility)
0.90 (Low)
Price
$0.38
Volume
7,041,707.603
Open
$0.38
Price
$0.38
Volume
7,041,707.603
Open
$0.38
Previous Close
$0.38
Daily Range
$0.36 - $0.40
52-Week Range
$0.16 - $1.47
Dividend
$0.00
Beta (Volatility)
0.90 (Low)
Price
$0.38
Volume
7,041,707.603
Open
$0.38
Previous Close
$0.38
Daily Range
$0.36 - $0.40
52-Week Range
$0.16 - $1.47
TOVX News
Is Coach a Rule Breaker?
eBay Made Easy
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Theriva Biologics
Industry
Biotechnology
Sector
Health CareEmployees
16
CEO
Steven A. Shallcross, MBA, CPA
Website
www.therivabio.comHeadquarters
Rockville, MD 20850, US
TOVX Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-138%
Return on Capital
-88%
Return on Assets
-66%
Earnings Yield
-11.11%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$17.49M
Shares Outstanding
45.89M
Volume
7.04M
Short Interest
0.00%
Avg. Volume
25.61M
Financials (TTM)
Gross Profit
$108.00K
Operating Income
$15.02M
EBITDA
$14.91M
Operating Cash Flow
$16.67M
Capital Expenditure
$35.00K
Free Cash Flow
$16.70M
Cash & ST Invst.
$13.06M
Total Debt
$2.63M
Theriva Biologics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$27.00K
+0.0%
Gross Margin
0.00%
N/A
Market Cap
$17.49M
N/A
Market Cap/Employee
$874.25K
N/A
Employees
20
N/A
Net Income
$3.51M
+21.2%
EBITDA
$6.90M
+256.0%
Quarterly Fundamentals
Net Cash
$10.43M
+3.8%
Accounts Receivable
$3.83M
+15.4%
Inventory
$0.00
N/A
Long Term Debt
$2.02M
+109.6%
Short Term Debt
$606.00K
+1.0%
Return on Assets
-66.03%
N/A
Return on Invested Capital
-87.96%
N/A
Free Cash Flow
$2.88M
+38.6%
Operating Cash Flow
$2.88M
+38.6%